Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.
2.

Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma.

Bretton PR, Melamed MR, Fair WR, Cote RJ.

Prostate. 1994 Aug;25(2):108-14.

PMID:
7518596
4.
5.

DNA in situ sensitivity to denaturation in bladder cancer and its correlation with tumor stage.

Bretton PR, Darzynkiewicz Z, Henry E, Kimmel M, Fair WR, Melamed MR.

Cancer Res. 1990 Dec 15;50(24):7912-4.

6.

Voided urine flow cytometry in screening high-risk patients for the presence of bladder cancer.

Hermansen DK, Badalament RA, Bretton PR, Kimmel M, Aswad CM, Whitmore WF Jr, Melamed MR.

J Occup Med. 1990 Sep;32(9):894-7.

PMID:
2074515
7.

The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin.

Bretton PR, Herr HW, Kimmel M, Whitmore WF Jr, Laudone V, Oettgen HF, Fair WR.

J Urol. 1990 Apr;143(4):710-2; discussion 712-3.

PMID:
2313796
8.

Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin.

Bretton PR, Herr HW, Kimmel M, Fair WR, Whitmore WF Jr, Melamed MR.

J Urol. 1989 Jun;141(6):1332-6.

PMID:
2724430
9.

Initial evaluation of a new epithelial antigen (T16) for bivariate flow cytometry of bladder irrigation specimens.

Bretton PR, Myc A, Cordon-Cardo C, DeAngelis P, Fair WR, Melamed MR.

Cytometry. 1989 May;10(3):339-44.

10.

Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra.

Bretton PR, Herr HW, Whitmore WF Jr, Badalament RA, Kimmel M, Provet J, Oettgen HF, Melamed MR, Fair WR.

J Urol. 1989 Apr;141(4):853-6.

PMID:
2926879

Supplemental Content

Loading ...
Support Center